RecruitingNCT01620372

French Childhood Cancer Survivor Study

Constitution d'Une Cohorte Nationale rétrospective de Survivants d'un Cancer Solide de l'Enfant diagnostiqué Avant 2000


Sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Enrollment

18,000 participants

Start Date

Nov 1, 2011

Study Type

OBSERVATIONAL

Conditions

Summary

The FCCSS is a multicentric national large-scale collaborative population-based study of children treated for a solid tumor before 2000 in France and before the age of 19 years. The study is concerned by improving knowledge about the long-term effects caused by cancer and its treatments including adverse health and social outcomes. The main reason of the FCCSS is to estimate the risk of adverse health and social outcomes that may occur after a cancer treatment and to prevent them by providing adapted follow-up care. The cohort will be followed for up to 20 years from 2011.


Eligibility

Max Age: 18 Years

Inclusion Criteria4

  • All types of solid childhood cancer in France
  • Age at diagnosis: Below age 19
  • Period of diagnosis: between 1st January 1942 and 31st December 1999
  • Complete identification (first name, last name, date of birth and place of birth)

Exclusion Criteria1

  • Leukaemia cases

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(36)

Centre Hospital-Universitaire Hôpital Nord

Amiens, France

Centre Hospitalier-Universitaire

Angers, France

Centre Hospitalier Régional Universitaire Hôpital Saint-Jacques

Besançon, France

Groupe hospitalier Pellegrin

Bordeaux, France

Centre Hospitalier Universaitaire Hôpital Côte de Nacre

Caen, France

Centre Hospitalier Universitaire Hôpial Hôtel Dieu

Clermont-Ferrand, France

Centre Hospitalier Universaitaire hôpital d'enfants

Dijon, France

Hôpital La Tronche

Grenoble, France

Centre Oscar Lambret

Lille, France

Hôpital Jeanne De Flandre

Lille, France

Hôpital de la mère et de l'enfant

Limoges, France

Institut d'Hématologie et Oncologie Pédiatrique

Lyon, France

Centre Régional de Lutte Contre le Cancer Centre Léon Bérard

Lyon, France

Hôpital d'Enfants de Margency (HEM) Croix Rouge Française

Margency, France

AP-HM Hôpital de la Timone

Marseille, France

Hôpital Arnaud De Villeneuve

Montpellier, France

Centre Hospitalier Universaitaire Hôpital mère-enfant

Nantes, France

Centre Antoine Lacassagne

Nice, France

GCS Hôpitaux pédiatriques Centre Hospitalier Universitaire Lenval

Nice, France

Institut Curie

Paris, France

Hôpital Armand Trousseau

Paris, France

CHRU de Poitiers La Miletrie

Poitiers, France

Institut Jean Godinot

Reims, France

Centre Hospitalier Universitaire de Reims Hôpital Maison Blanche

Reims, France

Centre Hospitalier Universitaire Hôpital Sud

Rennes, France

Hôpital Charles-Nicolle

Rouen, France

Centre Hospitalier Universitaire Hôpital Nord

Saint-Etienne, France

Centre René Gauducheau de Nantes Atlantique

Saint-Herblain, France

Centre Hospitalier de Saintonge

Saintes, France

Hôpital Hautepierre

Strasbourg, France

Institut Claudius Regaud

Toulouse, France

Hôpital des Enfants

Toulouse, France

Hôpital Clocheville

Tours, France

Hôpital Brabois enfants CHU de Nancy

Vandœuvre-lès-Nancy, France

Centre Régional de Lutte Contre le Cancer de Lorraine ALEXIS VAUTRIN

Vandœuvre-lès-Nancy, France

Institut Gustave Roussy

Villejuif, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01620372


Related Trials